Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

MASSIVE DOSE ARSENOTHERAPY OF EARLY SYPHILIS BY INTRAVENOUS DRIP METHOD

MASSIVE DOSE ARSENOTHERAPY OF EARLY SYPHILIS BY INTRAVENOUS DRIP METHOD Previous papers have dealt with the pharmacologic work underlying the adoption of the continuous intravenous drip method,1 the clinical results in earlier series,2 the organization of the supervisory committee,3 the technical considerations for the administration of the drug,4 the serologic5 and chemical studies,6 the organization of the follow-up clinic, under the direction of Dr. Evan Thomas7 and Dr. Bruce Webster,8 and the public health aspects.9 THE PLAN OF STUDY Four groups of patients are included in the present summary (table 1). Group 1, studied in 1933, consisted of 25 patients2 who were given an average of 4 Gm. of neoarsphenamine over the course of five days. Group 2, studied in 1938, comprised 86 men10 treated in the same manner. Groups 1 and 2 constitute the neoarsphenamine series of 111 patients. Group 3, studied in 1938 and 1939, included 157 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

MASSIVE DOSE ARSENOTHERAPY OF EARLY SYPHILIS BY INTRAVENOUS DRIP METHOD

JAMA , Volume 117 (14) – Oct 4, 1941

Loading next page...
 
/lp/american-medical-association/massive-dose-arsenotherapy-of-early-syphilis-by-intravenous-drip-dyw2FQ7Rqx

References (5)

Publisher
American Medical Association
Copyright
Copyright © 1941 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1941.02820400012004
Publisher site
See Article on Publisher Site

Abstract

Previous papers have dealt with the pharmacologic work underlying the adoption of the continuous intravenous drip method,1 the clinical results in earlier series,2 the organization of the supervisory committee,3 the technical considerations for the administration of the drug,4 the serologic5 and chemical studies,6 the organization of the follow-up clinic, under the direction of Dr. Evan Thomas7 and Dr. Bruce Webster,8 and the public health aspects.9 THE PLAN OF STUDY Four groups of patients are included in the present summary (table 1). Group 1, studied in 1933, consisted of 25 patients2 who were given an average of 4 Gm. of neoarsphenamine over the course of five days. Group 2, studied in 1938, comprised 86 men10 treated in the same manner. Groups 1 and 2 constitute the neoarsphenamine series of 111 patients. Group 3, studied in 1938 and 1939, included 157

Journal

JAMAAmerican Medical Association

Published: Oct 4, 1941

There are no references for this article.